Drug Shortage Report for CEFUROXIME FOR INJECTION, USP

Last updated on 2020-10-31 History
Report ID 122228
Drug Identification Number 02422298
Brand name CEFUROXIME FOR INJECTION, USP
Common or Proper name CEFUROXIME FOR INJECTION, USP
Company Name HIKMA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) CEFUROXIME
Strength(s) 750MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25 VIALS
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-10-30
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-10-31
Company comments BUSINESS REASONS.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-08-13 English Compare
v2 2020-08-13 French Compare
v3 2020-10-31 English Compare

Showing 1 to 3 of 3